Literature DB >> 30337848

Molecular Level Understanding of the Reversible Phase Transformation between Forms III and II of Dapsone.

Doris E Braun1, Hannes Krüger2, Volker Kahlenberg2, Ulrich J Griesser1.   

Abstract

The reversible solid-state phase transformation between the neat forms II and III of dapsone (DDS) was studied using thermal analytical methods, variable temperature X-ray diffraction and solid-state modeling at the electronic level. The first order III ↔ II phase transformation occurs at 78 ± 4 °C with a heat of transition of 2 kJ mol-1 and a small hysteresis. The two isosymmetric polymorphs (both P212121) differ only in movement of layers of molecules and show a small variation in conformation. The combination of variable-temperature single-crystal structure determinations and pair-wise intermolecular energy calculations allowed us to unravel the single-to-single crystal transformation at a molecular level, to estimate the molecular contributions to the heat of transformation and to rationalize why the room and low temperature form III is the less dense polymorphic form, which is a rare phenomenon in enantiotropically related pairs of polymorphs in molecular crystals.

Entities:  

Keywords:  DDS; dapsone; intermolecular energy calculations; single-to-single crystal phase transformation; temperature-dependent X-ray diffraction; thermal analysis

Year:  2017        PMID: 30337848      PMCID: PMC6191030          DOI: 10.1021/acs.cgd.7b01089

Source DB:  PubMed          Journal:  Cryst Growth Des        ISSN: 1528-7483            Impact factor:   4.076


  14 in total

1.  A probabilistic approach to space-group determination from powder diffraction data.

Authors:  A J Markvardsen; W I David; J C Johnston; J C Johnson; K Shankland
Journal:  Acta Crystallogr A       Date:  2001-01       Impact factor: 2.290

2.  A century of the synthesis of dapsone: its anti-infective capacity now and then.

Authors:  R Wolf; R Orni-Wasserlauf
Journal:  Int J Dermatol       Date:  2000-10       Impact factor: 2.736

Review 3.  Solution-mediated phase transformation: significance during dissolution and implications for bioavailability.

Authors:  Kristyn Greco; Robin Bogner
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

4.  Accurate and Efficient Model Energies for Exploring Intermolecular Interactions in Molecular Crystals.

Authors:  Michael J Turner; Simon Grabowsky; Dylan Jayatilaka; Mark A Spackman
Journal:  J Phys Chem Lett       Date:  2014-11-26       Impact factor: 6.475

5.  The polymorphic drug substances of the European pharmacopoeia. Part 9. Physicochemical properties and crystal structure of acetazolamide crystal forms.

Authors:  U J Griesser; A Burger; K Mereiter
Journal:  J Pharm Sci       Date:  1997-03       Impact factor: 3.534

6.  Energy frameworks: insights into interaction anisotropy and the mechanical properties of molecular crystals.

Authors:  Michael J Turner; Sajesh P Thomas; Ming W Shi; Dylan Jayatilaka; Mark A Spackman
Journal:  Chem Commun (Camb)       Date:  2015-03-04       Impact factor: 6.222

7.  Graph-set analysis of hydrogen-bond patterns in organic crystals.

Authors:  M C Etter; J C MacDonald; J Bernstein
Journal:  Acta Crystallogr B       Date:  1990-04-01

Review 8.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

9.  4-(4-Amino-phenyl-sulfon-yl)aniline-1,3,5-trinitro-benzene (1/2).

Authors:  Graham Smith; Urs D Wermuth
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-01-21

Review 10.  Can computed crystal energy landscapes help understand pharmaceutical solids?

Authors:  Sarah L Price; Doris E Braun; Susan M Reutzel-Edens
Journal:  Chem Commun (Camb)       Date:  2016-04-12       Impact factor: 6.222

View more
  1 in total

1.  The Rich Solid-State Phase Behavior of dl-Aminoheptanoic Acid: Five Polymorphic Forms and Their Phase Transitions.

Authors:  Mireille M H Smets; Mateusz B Pitak; Joseph Cadden; Vincent R Kip; Gilles A de Wijs; Ernst R H van Eck; Paul Tinnemans; Hugo Meekes; Elias Vlieg; Simon J Coles; Herma M Cuppen
Journal:  Cryst Growth Des       Date:  2017-11-29       Impact factor: 4.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.